Ranibizumab frente a bevacizumab. Consideraciones farmacológicas
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference28 articles.
1. Therapeutic antibodies in ophthalmology: Old is new again;Magdelaine-Beuzelin;MAbs.,2010
2. Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro;Wang;Angiogenesis.,2004
3. Ranibizumab;Blick;Drugs,2007
4. Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo;Lowe;Exp Eye Res.,2007
5. Pharmacokinetics of intravitreal bevacizumab (Avastin);Bakri;Ophthalmology.,2007
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study;Frontiers in Pharmacology;2022-12-07
2. Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment;Borneo Journal of Pharmacy;2022-08-31
3. Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence;Kidney International;2019-09
4. In vitro characterization of new stabilizing albumin nanoparticles as a potential topical drug delivery system in the treatment of corneal neovascularization (CNV);Journal of Drug Delivery Science and Technology;2019-08
5. The Protective Roles of Folic Acid in Preventing Diabetic Retinopathy Are Potentially Associated with Suppressions on Angiogenesis, Inflammation, and Oxidative Stress;Ophthalmic Research;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3